Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Sabizabulin

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Sabizabulin - mCRPC- used now for Covid 19.

in response to

Re: Sabizabulin - mCRPC- used now for Covid 19.

fouremm

posted on Apr 16, 2022 07:27PM

It seems to me that management has been leaning towards licencing-type partnerships with the ones Zenith is collaborating with at present and possibly more to come.

Perhaps all we need is one successful collaboration, creating a gateway to a successful Zenith IPO.